Friday, October 05, 2018 7:22:58 PM
I would have to agree with West Coast Snapper...
Under Section 5 of the Securities Act of 1933, as amended (“Securities Act”), every “offer” of securities requires a registration or exemption from registration.
• “Offer” is broadly defined under Section 2(a)(3) of the Securities Act and therefore the private offering could be considered a violation of Section 5 (or “gun jumping”) by offering securities for sale prior to the filing of a registration statement for the public offering
• Filing a Form S-1 to register for the public offer can by itself be viewed as “general advertising” which negates the availability of most private placement exemptions
This S1 filing never became “effective” and therefore was easily withdrawn so as not to conflict with any current or future private placements.
Familiarizing yourself with SEC security laws and the filings that are associated with them can be very helpful...
GLTA
Under Section 5 of the Securities Act of 1933, as amended (“Securities Act”), every “offer” of securities requires a registration or exemption from registration.
• “Offer” is broadly defined under Section 2(a)(3) of the Securities Act and therefore the private offering could be considered a violation of Section 5 (or “gun jumping”) by offering securities for sale prior to the filing of a registration statement for the public offering
• Filing a Form S-1 to register for the public offer can by itself be viewed as “general advertising” which negates the availability of most private placement exemptions
This S1 filing never became “effective” and therefore was easily withdrawn so as not to conflict with any current or future private placements.
Familiarizing yourself with SEC security laws and the filings that are associated with them can be very helpful...
GLTA
DISCLAIMER: Anything that I may post should be viewed as a personal opinion. Do not misconstrue these opinions as investment or trading advice. All posts are for entertainment purposes only!
Recent RDGL News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2026 08:45:22 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/28/2026 08:44:48 PM
- Form QUALIF - Notice of Qualification [Regulation A] • Edgar (US Regulatory) • 03/06/2026 05:15:04 AM
- Form 1-A/A - Offering Statement [Regulation A]: [Amend] • Edgar (US Regulatory) • 03/04/2026 04:48:52 PM
- Vivos Inc. Diversifies Manufacturing Base with Planned U.S. and International Production Sites • GlobeNewswire Inc. • 02/17/2026 01:30:00 PM
- Vivos Inc. Announces Significant Progress Toward FDA Investigational Device Exemption (IDE) Submission for RadioGel® Precision Radionuclide Therapy™ • GlobeNewswire Inc. • 02/10/2026 01:30:00 PM
- Vivos Inc Updates Human Therapy Progress in India • GlobeNewswire Inc. • 02/03/2026 01:30:00 PM
- Vivos Inc. Strengthens Patent Protection with New U.S. Patent Issuance and PRECISIONGEL™ Trademark Approvals • GlobeNewswire Inc. • 01/28/2026 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2026 04:06:21 PM
- Vivos Inc Summarizes Progress in its Animal Therapy Division • GlobeNewswire Inc. • 12/22/2025 05:56:08 PM
- Vivos Inc Summarzes Preogress in its Animal Therapy Division • GlobeNewswire Inc. • 12/22/2025 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/09/2025 09:00:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2025 12:34:42 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2025 11:08:03 AM
- Vivos Inc. Issues Shareholder Update Letter • GlobeNewswire Inc. • 11/06/2025 01:30:00 PM
- Vivos Inc. Strengthens Strategic Collaboration with Exubrion Therapeutics • GlobeNewswire Inc. • 10/29/2025 12:30:00 PM
- Vivos Inc. Retains Top FDA Regulatory Expert Dr. John J. Smith, M.D., J.D., to Support IDE Submission for RadioGel® • GlobeNewswire Inc. • 10/27/2025 12:30:00 PM
- Vivos Inc Board Authorizes Vivos Inc to Establish a Corporate Entity in India • GlobeNewswire Inc. • 09/29/2025 05:46:00 PM
- Vivos Inc Board Authorizes Vivios Inc to Establish a Corporate Entity in India • GlobeNewswire Inc. • 09/29/2025 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2025 08:01:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2025 07:32:46 PM
